INmune Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21.36	24.75	20.92	35.85	52.15	74.81
Cash & Short-Term Investments	21.36	24.75	20.92	35.85	52.15	74.81
Cash Growth	10.45%	18.30%	-41.64%	-31.26%	-30.29%	240.56%
Other Receivables	0.77	4.54	1.41	2.44	8.46	5.5
Total Trade Receivables	0.77	4.54	1.41	2.44	8.46	5.5
Other Current Assets	0.69	0.6	0.33	1.65	4.06	2.29
Total Current Assets	22.82	29.89	22.66	39.94	64.68	82.61
Net Property, Plant & Equipment	2.31	1.87	0.31	0.41	0.51	0.73
Other Intangible Assets	-	-	16.51	16.51	16.51	16.51
Other Long-Term Assets	0.68	0.6	0.08	0.13	0.1	0.1
Total Assets	25.82	32.35	39.56	57	81.8	99.95
Accounts Payable	4.68	7.79	6.56	7.94	5.22	3.81
Accrued Expenses	4.68	7.79	6.56	7.94	5.22	3.81
Current Portion of Long-Term Debt	-	-	-	9.92	5	-
Current Portion of Leases	0.7	0.62	0.14	0.12	0.09	0.07
Other Current Liabilities	-	-	0.52	0.49	0.62	0.47
Total Current Liabilities	5.39	8.42	7.22	18.47	10.92	4.36
Long-Term Debt	-	-	-	-	9.7	14.46
Long-Term Leases	0.81	0.41	0.24	0.4	0.53	0.7
Other Long-Term Liabilities	-	-	-	-	0.55	0.2
Total Long-Term Liabilities	0.81	0.41	0.24	0.4	10.77	15.36
Total Liabilities	6.19	8.83	7.47	18.86	21.69	19.72
Common Stock	0.03	0.03	0.02	0.02	0.02	0.02
Additional Paid-in Capital	234.77	233.27	195.75	159.14	151.8	143.92
Accumulated Other Comprehensive Income	-0.73	-0.74	-0.58	-0.8	-0.7	0
Retained Earnings	-	-	-	-121.02	-91.01	-63.72
Total Common Shareholders' Equity	234.07	232.56	195.2	37.34	60.1	80.23
Minority Interest	-	-	-	0.8	-	-
Shareholders' Equity	234.07	232.56	195.2	38.14	60.1	80.23
Total Liabilities & Equity	25.82	32.35	39.56	57	81.8	99.95
Total Debt	1.51	1.03	0.38	10.44	15.31	15.23
Net Cash (Debt)	19.85	23.72	20.54	25.41	36.84	59.58
Net Cash Growth	-16.31%	15.48%	-19.18%	-31.03%	-38.16%	173.20%
Net Cash Per Share	0.77	0.96	1.03	1.41	2.06	3.69
Book Value	234.07	232.56	195.2	37.34	60.1	80.23
Book Value Per Share	9.08	9.39	9.79	2.08	3.35	4.97
Tangible Book Value	234.07	232.56	178.69	20.83	43.59	63.71
Tangible Book Value Per Share	9.08	9.39	8.96	1.16	2.43	3.95

SEC Filings: 10-K · 10-Q